Disclosure Panels Details Page
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic Panel - Disclosures as of 05/29/2023
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Zahraa AlHilli MD | None | None | None | None | 01/30/2023 |
| Banu Arun MD | AstraZeneca Pharmaceuticals LP | None | None | None | 02/13/2023 |
| Marian Birkeland PhD | None | None | None | None | 12/12/2022 |
| Nicole Blankenhorn | None | None | None | None | 03/21/2023 |
| Saundra Buys MD | None | None | None | None | 03/27/2023 |
| Heather Cheng PhD,MD | Clovis Oncology Color Health, Inc Janssen Pharmaceutica Products, LP Promontory Therapeutics (formerly Phosplatin) |
None | None | UpToDate | 01/22/2023 |
| Jane Churpek MS,MD | Department of Defense NIH |
MDS Foundation RUNX1 Research Program |
UpToDate,Inc | MDS Foundation|RUNX1 Research Program | 01/28/2023 |
| Mary Daly PhD,MD,FACP | None | None | None | None | 05/12/2023 |
| Susan Darlow PhD | None | None | None | None | 01/04/2023 |
| Susan Domchek MD | None | None | None | None | 01/26/2023 |
| Mary Dwyer MS | None | None | None | None | 05/11/2023 |
| Susan Friedman DVM | None | None | None | None | 02/05/2023 |
| Veda Giri MD | None | None | None | None | 05/23/2023 |
| Michael Goggins | None | None | None | None | 03/23/2023 |
| Kristina Gregory MSN,RN,OCN | None | None | None | None | 03/13/2023 |
| Andrea Hagemann MD,MSCI | None | None | None | None | 02/15/2023 |
| Ashley Hendrix MD,MBA | None | None | None | None | 03/30/2023 |
| Erin Hesler | None | None | None | None | 04/04/2023 |
| Mollie Hutton MS,CGC | None | None | None | None | 02/22/2023 |
| Robin Isaac PharmD | None | None | None | None | 01/17/2023 |
| Beth Karlan MD | GRAIL | BioRad Bluestar Genomics Global Coalition for Adaptive Research Mercy BioAnalytics Natera Ovarian Cancer Research Alliance |
None | None | 02/02/2023 |
| Nawal Kassem MD,MS | None | None | None | None | 10/18/2022 |
| Seema Khan MD | None | Besins Healthcare Ireland Ltd. | None | None | 02/20/2023 |
| Katia Khoury MD | None | None | None | None | 05/12/2023 |
| Wendy Kohlmann MS,CGC | None | None | None | None | 01/31/2023 |
| Allison Kurian MSc,MD | Ambry Genetics Myriad Genetic Laboratories, Inc. |
None | None | None | 02/23/2023 |
| Christine Laronga MD,FACS | None | None | None | Royalties for editorial work | 05/24/2023 |
| Julie Mak MS,MSc,CGC | None | None | VSee | VSee | 12/13/2022 |
| John Mansour MD | None | None | None | None | 02/14/2023 |
| Kara Maxwell PhD,MD | None | None | None | None | 02/14/2023 |
| Kevin McDonnell PhD,MD | None | None | None | None | 05/03/2023 |
| Carolyn Menendez MD | None | None | None | None | 05/17/2023 |
| Sofia Merajver PhD,MD | None | None | None | Founder and equity interest in InheRET, Inc. I do not believe that any change in the guidelines would benefit or harm the commercial potential of InheRET, Inc. | 02/14/2023 |
| Barbara Norquist MD | None | None | None | None | 04/07/2023 |
| Kenneth Offit MD,MPH | AnaNeo Therapeutics | None | None | None | 04/06/2023 |
| Tuya Pal MD | None | Natera | None | None | 05/26/2023 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 05/11/2023 |
| Dominique Rash MD | None | None | Varian Medical Systems, Inc. VisionRT |
None | 03/23/2023 |
| Gwen Reiser MS,CGC | None | None | None | None | 04/24/2023 |
| Leigha Senter-Jamieson MS,CGC | None | AstraZeneca Pharmaceuticals LP | AstraZeneca Pharmaceuticals LP GlaxoSmithKline |
None | 02/01/2023 |
| Kristen Shannon MS,CGC | None | Expert Witness | None | None | 02/14/2023 |
| Kala Visvanathan MD,MHS | Cepheid Optra Health |
None | None | None | 04/06/2023 |
| Jeanna Welborn MD | None | None | None | None | 02/16/2023 |
| Myra Wick PhD,MD | Natera | American board of Medical Genetics and Genomics (ABMGG) | None | None | 02/09/2023 |
| Marie Wood MD | None | None | None | None | 02/04/2023 |
| Matthew Yurgelun MD | Janssen Pharmaceutica Products, LP | UpToDate | None | Facing Our Risk of Cancer Empowered (FORCE) advocacy group | 01/28/2023 |